Prevalence of neurodevelopmental disorders in Duchenne muscular dystrophy in Srinagarind Hospital

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

TCTR

Registry ID

TCTR20220302005

Enrollment

Registered

2022-03-02

Start date

2022-03-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prevalence of neurodevelopmental disorders in Duchenne muscular dystrophy in Srinagarind Hospital Neurodevelopmental disorders, Duchenne muscular dystrophy, Attention Deficit Hyperactivity Disorder, ADHD, Autism Spectrum Disorder, ASD, Specific learning disorder, LD, Intellectual disabilities, ID

Interventions

Childrens who diagnosed Duchenne muscular dystrophy under 18 year-old

Diagnostic

Duchenne muscular dystrophy patients

Eligibility

Sex/Gender

All

Age

No minimum to 18 Years

Inclusion criteria

Inclusion criteria: Childrens who diagnosed Duchenne muscular dystrophy under 18 year-old

Exclusion criteria

Exclusion criteria: Childrens who diagnosed Duchenne muscular dystrophy under 18 year-old unwilled to participate in this study

Design outcomes

Primary

Measure	Time frame
Attention Deficit Hyperactivity Disorder 12 months Questionnaire,Autistic Spectrum Disorder 12 months Questionnaire,Developmental level 12 months DENVERII, Geselle,Intelligence Quotient 12 months IQ testing	—

Secondary

Measure	Time frame
Correlation between genotype, phenotype in DMD patients 12 months Multiplex Ligation-Dependent Probe Amplification	—

Countries

Thailand

Contacts

Public ContactPranchalee Sribootta

Pediatric Department, Faculty of Medicine, Khon Kaen University

pransri@kku.ac.th0874557041

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026